Home › Funds › EcoR1 Capital, LLC › ORIC
EcoR1 Capital, LLC position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
EcoR1 Capital, LLC reported holding 6,728,116 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$72.9M, representing 3.74% of its reported portfolio and ranking #6 among its reported holdings. EcoR1 Capital, LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's ORIC position evolved
EcoR1 Capital, LLC first disclosed a stake in ORIC in Q3 2023 at 3,418,068 shares (US$20.7M). The position peaked in Q1 2026 at 6,728,116 shares, worth US$85.2M. Across 12 filings, EcoR1 Capital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 6,728,116 shares valued at US$72.9M. Notable position changes include a 53% trim in Q2 2025 (shares rose 18% over the following quarter), a 316% increase in Q3 2025 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.42M | $20.68M | New |
| Q4 2023 | 3.42M | $31.45M | Hold |
| Q1 2024 | 3.42M | $47.00M | Hold |
| Q2 2024 | 3.42M | $24.17M | Hold |
| Q3 2024 | 3.42M | $35.04M | Hold |
| Q4 2024 | 3.42M | $27.58M | Hold |
| Q1 2025 | 3.42M | $19.07M | Hold |
| Q2 2025 | 1.62M | $16.42M | Reduce |
| Q3 2025 | 6.73M | $80.74M | Add |
| Q4 2025 | 6.73M | $55.04M | Hold |
| Q1 2026 | 6.73M | $85.25M | Hold |
| Q2 2026 | 6.73M | $72.87M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M), Venrock Adviser, LLC (US$46.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- Siren, L.L.C. 3.00M sh · $32.47M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Vivo Capital, LLC 1.85M sh · $20.02M · Q2 2026
- Defilade Capital Management, L.P. 1.05M sh · $11.35M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held ORIC?
EcoR1 Capital, LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is EcoR1 Capital, LLC's current position in ORIC?
As of Q2 2026, EcoR1 Capital, LLC holds 6.73M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $72.87M, representing 3.74% of its reported portfolio and ranking #6.
Has EcoR1 Capital, LLC been buying or selling ORIC?
In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in ORIC. The position peaked in Q1 2026 at 6.73M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., SR ONE CAPITAL MANAGEMENT, LP, Venrock Adviser, LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.